Clinical Research Directory
Browse clinical research sites, groups, and studies.
REDCURE Registry for Chronic Kidney Disease (CKD) Anemia
Sponsor: Nabiqasim Industries (Pvt) Ltd
Summary
A local registry on CKD-associated anemia aims to provide real-world insights into disease burden, treatment patterns, and outcomes at the national level. It helps capture variations in anemia severity with CKD stages, therapeutic practices and their response. It also supports evidence-based decision-making, identifies gaps in care, and informs locally relevant guidelines and policy planning to improve patient outcomes with oral novel therapy i.e. daprodustat
Official title: Registry of Daprodustat in Chronic Kidney Disease (CKD) Anemia for Understanding Real-World Evidence (REDCURE)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
384
Start Date
2026-01-30
Completion Date
2027-05-31
Last Updated
2026-01-20
Healthy Volunteers
No
Conditions
Interventions
Daprodustat
Hypoxia Inducible Factor (HIF) Prolyl Hydroxylase Inhibitor (PHI) drug